Loading...

Novartis India Limited

NOVARTIND.NS•NSE
Healthcare
Drug Manufacturers - Specialty & Generic
₹1036.60
₹6.10(0.59%)
Indian Market opens in 11h 11m

Novartis India Limited (NOVARTIND.NS) Stock Overview

Explore Novartis India Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap25.3B
P/E Ratio25.95
EPS (TTM)$39.37
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$616.77

NOVARTIND.NS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novartis India Limited (NOVARTIND.NS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 61.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $616.77.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.95 and a market capitalization of 25.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.41%
5-Day Change
-2.44%
1-Month Change
3.10%
3-Month Change
3.10%
6-Month Change
3.10%
Year-to-Date (YTD) Change
3.10%
1-Year Change
3.10%
3-Year Change
72.65%
5-Year Change
60.56%
All-Time (Max) Change
50.30%

Contact Information

https://www.novartis.in
91 22 5024 3000
Inspire BKC, G Block, Mumbai, NaN, 400051

Company Facts

620 Employees
IPO DateOct 7, 2020
CountryIN

Frequently Asked Questions